Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series B
Biotech
Big Pharma backers return for Aktis' $175M series B
Eli Lilly was one of a number of Aktis’ returning backers that also included Bristol Myers Squibb and Merck & Co.’s MRL Ventures Fund.
James Waldron
Sep 30, 2024 8:00am
Mendaera grabs $73M for handheld, needle-based robotics system
Sep 27, 2024 11:30am
Vicebio hauls in $100M series B to push RSV shot through phase 1
Sep 23, 2024 3:00am
SpectraWAVE collects $50M for coronary imaging catheters and AI
Sep 11, 2024 8:00am
Pathalys raises $105M to prepare kidney disease drug for FDA
Aug 20, 2024 10:00am
Halda's $126M will advance 'hold and kill' tumor drugs
Aug 12, 2024 7:00am